Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference

Thursday, September 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals will participate in the Wells Fargo 21st Annual Healthcare Conference on September 10th at 10:15 a.m. ET. The event will feature a fireside chat with management, and a live webcast will be available on the company's website. A replay of the webcast will also be accessible post-conference.

Market Sentiment Analysis

POSITIVE FACTORS

  • Ironwood Pharmaceuticals is actively engaging with investors.
  • Participation in a prominent healthcare conference enhances visibility.
  • Live webcast allows broader access to company updates.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)

Full Press Release Details

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10th at 10:15 a.m. ET. A live webcast of Ironwood’s fireside chat will be accessible through the Investors & Media section of the company’s website at www.ironwoodpharma.com. A replay of the webcast will be available on Ironwood’s website following the conference. About Ironwood

Frequently Asked Questions

When will Ironwood participate in the conference?

Ironwood will participate on September 10th at 10:15 a.m. ET.

How can I access the conference webcast?

The webcast will be available through Ironwood's Investors & Media section on their website.

Will there be a replay of the webcast?

Yes, a replay will be available on Ironwood's website after the conference.

What type of event is this for Ironwood?

It is a fireside chat at the Wells Fargo Annual Healthcare Conference.

ShareAdd on Google
Tags: IRWD Viatris Investor Conferences Healthcare Ironwood Pharmaceuticals Wells Fargo healthcare conference investor relations
Last updated: Sep 3, 2026

Biotech snapshot

Cash runway
$79M liquidity · $0M/mo burn
Low dilution risk
Lead asset
IW-3718Phase 3
Gastroesophageal Reflux Disease (GERD) →

Catalyst track record

+57%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →